Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Income from Continuing Operations (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Income from Continuing Operations for 12 consecutive years, with 26087000.0 as the latest value for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 44.35% year-over-year to 26087000.0; the TTM value through Mar 2026 reached 183587000.0, down 63.44%, while the annual FY2025 figure was 204378000.0, 110.68% down from the prior year.
  • Income from Continuing Operations hit 26087000.0 in Q1 2026 for Wave Life Sciences, up from 53179000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 29253000.0 in Q4 2024 and bottomed at 61780000.0 in Q3 2024.
  • Average Income from Continuing Operations over 5 years is 32163882.35, with a median of 37814000.0 recorded in 2022.
  • On a YoY basis, Income from Continuing Operations climbed as much as 279.95% in 2024 and fell as far as 949.21% in 2024.
  • Wave Life Sciences' Income from Continuing Operations stood at 43709000.0 in 2022, then surged by 62.81% to 16256000.0 in 2023, then soared by 279.95% to 29253000.0 in 2024, then plummeted by 281.79% to 53179000.0 in 2025, then surged by 50.94% to 26087000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 26087000.0, 53179000.0, and 53852000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.